Analytical Data
-
基因名
CD97
- Application
-
别名
TM7LN1; TM7-LN1; Seven-Span Transmembrane Protein; Seven-Transmembrane,Heterodimeric Receptor Associated With Inflammation; Seven Transmembrane Helix Receptor
-
种属
Human
-
表达系统
E. coli
-
标签
N- His & GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P48960
-
表达区间
Pro58~Met260
-
分子量
52kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CD97, a member of the EGF-TM7 family of adhesion receptors, plays a significant role in various biological processes, including cell adhesion, migration, and immune responses. It is characterized by its unique structure, which includes a large extracellular domain containing several EGF-like repeats and a single transmembrane domain. CD97 is expressed in various tissues and cell types, and its expression patterns have been linked to different physiological and pathological conditions, such as inflammation, cancer metastasis, and immune disorders. The study of CD97 recombinant proteins has gained attention as researchers aim to elucidate its functional mechanisms and therapeutic potential. Recombinant CD97 proteins can be used to investigate the receptor's binding interactions with ligands, its signaling pathways, and its role in cell behavior. Additionally, understanding CD97's involvement in disease contexts, like tumor progression and autoimmune diseases, highlights the need for targeted interventions. The ability to produce CD97 as a recombinant protein facilitates the development of novel therapeutic strategies, including monoclonal antibodies and antagonists that could modulate its activity in disease settings. Overall, research on CD97 recombinant proteins is crucial for advancing our knowledge of this receptor's biological significance and its potential as a therapeutic target.
